Epstein Secrets

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

529,017 $63,000 plus: Other current assets 7,773 10,345 21,445 29,551 less:Current liabilities (22,612) (24,663) (42,832) (39,775) plus: Sbartiemi debt 0 0 0 0 DFNWC $23,661 $19,793 57,630 $52,776 as % of annualird revenue 16.3% 28.1% 8.8% 36.5% less: Excess cash 19,1331 (9.078)

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

529,017 $63,000 plus: Other current assets 7,773 10,345 21,445 29,551 less:Current liabilities (22,612) (24,663) (42,832) (39,775) plus: Sbartiemi debt 0 0 0 0 DFNWC $23,661 $19,793 57,630 $52,776 as % of annualird revenue 16.3% 28.1% 8.8% 36.5% less: Excess cash 19,1331 (9.078)

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

529,017 $63,000 plus: Other current assets 7,773 10,345 21,445 29,551 less:Current liabilities (22,612) (24,663) (42,832) (39,775) plus: Sbartiemi debt 0 0 0 0 DFNWC $23,661 $19,793 57,630 $52,776 as % of annualird revenue 16.3% 28.1% 8.8% 36.5% less: Excess cash 19,1331 (9.078)